The High Court won’t hear an appeal in a case by Acciona and Ferrovial against three insurers over coverage for loss and damage resulting from heavy rainfall at the site of construction of the Pacific Highway in northern New South Wales.
The corporate regulator has filed a suit against fintech giant PayPal over a term in its contracts with small businesses that sets a deadline for complaints about excess fees.
The Australian Competition and Consumer Commission has taken eHarmony Inc to court, alleging the dating site misled users about its advertised ‘free dating’ membership and that its automatic renewal was a “subscription trap”.
The Australian Securities and Investments Commission has won its case against Finnish microloan company Ferratum alleging it overcharged vulnerable, low-income consumers during the height of the COVID-19 pandemic.
A judge has approved a bid to consolidate two shareholder class actions against Medibank over a cyberattack that affected 10 million customers, finding that having two firms on the record is better than a carriage contest.
The receivers of Melissa Caddick’s estate have reached an in-principle agreement with the Sydney frauster’s husband and son in relation to the division of a small number of remaining assets.
Automotive electronics company Directed Electronics has lost its bid to revive copyright claims against a form business partner who it pursued as part of litigation over a scheme by two former employees to misappropriate its trade secrets through a secret side agreement with South Korean giant Hanhwa.
A patient who gave his plastic surgeon a one-star review for a nose job is challenging a judgment that put him on the hook for $50,000 in defamation damages.
A class action against Volkswagen over allegedly deadly Takata airbags has failed a second time after an appeals court found “a merely speculative” risk of rupture was not enough to find the vehicles unacceptable.
On the first day of a seven-week trial, the applicant in a class action against Monsanto has taken aim at the agrochemical giant’s “same old approach” to undermining decades of evidence it says demonstrates the cancer-causing properties of popular weed killer Roundup.